157 related articles for article (PubMed ID: 37019729)
21. A prospective, multicenter, international study to explore the effect of three different amplitude settings in female subjects with urinary urge incontinence receiving interstim therapy.
Elterman D; Ehlert M; De Ridder D; McCrery R; Pakzad M; Kaufman MR; Shah S; Margolis E; Bukkapatnam R; Johnson G; Zirpel L; Stolen K; Champs M; Goudelocke C
Neurourol Urodyn; 2021 Mar; 40(3):920-928. PubMed ID: 33645864
[TBL] [Abstract][Full Text] [Related]
22. Twelve-month Durability of a Fully-implanted, Nickel-sized and Shaped Tibial Nerve Stimulator for the Treatment of Overactive Bladder Syndrome with Urgency Urinary Incontinence: A Single-Arm, Prospective Study.
Gilling P; Meffan P; Kaaki B; MacDiarmid S; Lucente V; Clark M; Sen SK; English S; Sand PK
Urology; 2021 Nov; 157():71-78. PubMed ID: 34048826
[TBL] [Abstract][Full Text] [Related]
23. Two-year outcomes of the ARTISAN-SNM study for the treatment of urinary urgency incontinence using the Axonics rechargeable sacral neuromodulation system.
Pezzella A; McCrery R; Lane F; Benson K; Taylor C; Padron O; Blok B; de Wachter S; Gruenenfelder J; Pakzad M; Perrouin-Verbe MA; van Kerrebroeck P; Mangel J; Peters K; Kennelly M; Shapiro A; Lee U; Comiter C; Mueller M; Goldman HB
Neurourol Urodyn; 2021 Feb; 40(2):714-721. PubMed ID: 33508155
[TBL] [Abstract][Full Text] [Related]
24. Percutaneous tibial nerve stimulation for the long-term treatment of overactive bladder: 3-year results of the STEP study.
Peters KM; Carrico DJ; Wooldridge LS; Miller CJ; MacDiarmid SA
J Urol; 2013 Jun; 189(6):2194-201. PubMed ID: 23219541
[TBL] [Abstract][Full Text] [Related]
25. Refractory urgency urinary incontinence treatment in women: impact of age on outcomes and complications.
Komesu YM; Amundsen CL; Richter HE; Erickson SW; Ackenbom MF; Andy UU; Sung VW; Albo M; Gregory WT; Paraiso MF; Wallace D;
Am J Obstet Gynecol; 2018 Jan; 218(1):111.e1-111.e9. PubMed ID: 29031894
[TBL] [Abstract][Full Text] [Related]
26. A Multicenter Study Evaluating the FREquency of Use and Efficacy of a Novel Closed-Loop Wearable Tibial Neuromodulation System for Overactive Bladder and Urgency Urinary Incontinence (FREEOAB).
Goudelocke C; Sobol J; Poulos D; Enemchukwu E; Zaslau S; Dhir R
Urology; 2024 Jan; 183():63-69. PubMed ID: 37944596
[TBL] [Abstract][Full Text] [Related]
27. One-year outcomes of the ARTISAN-SNM study with the Axonics System for the treatment of urinary urgency incontinence.
Benson K; McCrery R; Taylor C; Padron O; Blok B; de Wachter S; Pezzella A; Gruenenfelder J; Pakzad M; Perrouin-Verbe MA; Van Kerrebroeck P; Mangel J; Peters K; Kennelly M; Shapiro A; Lee U; Comiter C; Mueller M; Goldman H; Lane F
Neurourol Urodyn; 2020 Jun; 39(5):1482-1488. PubMed ID: 32339339
[TBL] [Abstract][Full Text] [Related]
28. Intermediate-term results of a prospective, multicenter study on remote programming sacral neuromodulation for refractory overactive bladder.
Zhang Y; Meng L; Zhang P; Tian X; Chen G; Li Y; Zhang Y; Xu Z; Wei Z; Zhang W; Ma L; Shi B; Liao L; Wang J
Transl Androl Urol; 2021 May; 10(5):1966-1975. PubMed ID: 34159077
[TBL] [Abstract][Full Text] [Related]
29. Flat Magnetic Stimulation for Urge Urinary Incontinence.
Barba M; Cola A; Rezzan G; Costa C; Re I; Volontè S; Terzoni S; Frigerio M; Maruccia S
Medicina (Kaunas); 2023 Nov; 59(11):. PubMed ID: 38004048
[No Abstract] [Full Text] [Related]
30. Refractory overactive bladder after urethrolysis for bladder outlet obstruction: management with sacral neuromodulation.
Starkman JS; Duffy JW; Wolter CE; Kaufman MR; Scarpero HM; Dmochowski RR
Int Urogynecol J Pelvic Floor Dysfunct; 2008 Feb; 19(2):277-82. PubMed ID: 17671752
[TBL] [Abstract][Full Text] [Related]
31. Effect of pulse width variations on sacral neuromodulation for overactive bladder symptoms: A prospective randomized crossover feasibility study.
Rueb J; Goldman HB; Vasavada S; Moore C; Rackley R; Gill BC
Neurourol Urodyn; 2023 Apr; 42(4):770-777. PubMed ID: 36840886
[TBL] [Abstract][Full Text] [Related]
32. Urodynamic evaluation of sacral neuromodulation for urge urinary incontinence.
Groenendijk PM; Lycklama à Nyeholt AA; Heesakkers JP; van Kerrebroeck PE; Hassouna MM; Gajewski JB; Cappellano F; Siegel SW; Fall M; Dijkema HE; Jonas U; van den Hombergh U;
BJU Int; 2008 Feb; 101(3):325-9. PubMed ID: 18070199
[TBL] [Abstract][Full Text] [Related]
33. Sacral neuromodulation for female pelvic floor disorders.
El-Azab AS; Siegel SW
Arab J Urol; 2019 Mar; 17(1):14-22. PubMed ID: 31258941
[No Abstract] [Full Text] [Related]
34. OnabotulinumtoxinA vs Sacral Neuromodulation on Refractory Urgency Urinary Incontinence in Women: A Randomized Clinical Trial.
Amundsen CL; Richter HE; Menefee SA; Komesu YM; Arya LA; Gregory WT; Myers DL; Zyczynski HM; Vasavada S; Nolen TL; Wallace D; Meikle SF
JAMA; 2016 Oct; 316(13):1366-1374. PubMed ID: 27701661
[TBL] [Abstract][Full Text] [Related]
35. Affective symptoms and quality of life in patients with voiding or storage dysfunction: Results before and after sacral neuromodulation: A prospective follow-up study.
Jairam R; Drossaerts J; Vrijens D; Leue C; van Kerrebroeck P; van Koeveringe G
Neurourol Urodyn; 2018 Jun; 37(5):1801-1808. PubMed ID: 29504634
[TBL] [Abstract][Full Text] [Related]
36. Sacral neuromodulation for lower urinary tract dysfunction and impact on erectile function.
Lombardi G; Mondaini N; Giubilei G; Macchiarella A; Lecconi F; Del Popolo G
J Sex Med; 2008 Sep; 5(9):2135-40. PubMed ID: 18637993
[TBL] [Abstract][Full Text] [Related]
37. Detailed Investigation of Bladder Diary Parameters During Sacral Neuromodulation in Patients With Overactive Symptoms.
Van de Borne S; Tilborghs S; Vaganée D; Vermandel A; De Wachter S
Neuromodulation; 2023 Dec; 26(8):1831-1835. PubMed ID: 36266179
[TBL] [Abstract][Full Text] [Related]
38. Increasing patient preparedness for sacral neuromodulation improves patient reported outcomes despite leaving objective measures of success unchanged.
Firoozi F; Gill B; Ingber MS; Moore CK; Rackley RR; Goldman HB; Vasavada SP
J Urol; 2013 Aug; 190(2):594-7. PubMed ID: 23499745
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and Safety of Sacral Neuromodulation by Converting Constant Frequency Stimulation Into Variable Frequency Stimulation in Patients With Detrusor Overactivity and Impaired Contractility: A Single-Center Prospective Study.
Zhu W; Shan S; Zhang G; Zhang Q; Zhang J; Che Y; Wen J; Wang Q
Neuromodulation; 2023 Dec; 26(8):1836-1844. PubMed ID: 35977853
[TBL] [Abstract][Full Text] [Related]
40. Specific Changes in Brain Activity during Urgency in Women with Overactive Bladder after Successful Sacral Neuromodulation: A Functional Magnetic Resonance Imaging Study.
Weissbart SJ; Bhavsar R; Rao H; Wein AJ; Detre JA; Arya LA; Smith AL
J Urol; 2018 Aug; 200(2):382-388. PubMed ID: 29630979
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
